American Healthcare REIT (NYSE:AHR – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Truist Financial in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock, up from their prior price objective of $16.00. Truist Financial’s price objective suggests a potential upside of 16.36% from the company’s previous close.
AHR has been the topic of a number of other research reports. Royal Bank of Canada began coverage on American Healthcare REIT in a research note on Monday, March 4th. They set an “outperform” rating and a $15.00 target price on the stock. Barclays initiated coverage on American Healthcare REIT in a report on Thursday, March 14th. They set an “overweight” rating and a $18.00 target price for the company. JMP Securities restated a “market outperform” rating and issued a $16.00 price target on shares of American Healthcare REIT in a research note on Thursday, May 16th. Bank of America started coverage on shares of American Healthcare REIT in a research note on Monday, March 4th. They issued a “buy” rating and a $15.00 price objective for the company. Finally, Morgan Stanley started coverage on shares of American Healthcare REIT in a research report on Monday, March 4th. They set an “overweight” rating and a $17.00 target price on the stock. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $16.00.
Check Out Our Latest Stock Analysis on American Healthcare REIT
American Healthcare REIT Price Performance
Insider Activity at American Healthcare REIT
In other American Healthcare REIT news, CEO Danny Prosky purchased 25,000 shares of the stock in a transaction dated Wednesday, May 22nd. The stock was bought at an average price of $14.20 per share, with a total value of $355,000.00. Following the acquisition, the chief executive officer now owns 108,333 shares of the company’s stock, valued at $1,538,328.60. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Hedge Funds Weigh In On American Healthcare REIT
A number of institutional investors have recently added to or reduced their stakes in AHR. Virtu Financial LLC acquired a new stake in American Healthcare REIT in the first quarter valued at approximately $308,000. Kodai Capital Management LP bought a new position in shares of American Healthcare REIT in the 1st quarter valued at $336,000. Peak Financial Advisors LLC acquired a new stake in shares of American Healthcare REIT during the 1st quarter valued at $416,000. Quadrature Capital Ltd bought a new stake in American Healthcare REIT during the 1st quarter worth $914,000. Finally, Seven Grand Managers LLC acquired a new position in American Healthcare REIT in the 1st quarter worth about $1,032,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Recommended Stories
- Five stocks we like better than American Healthcare REIT
- Learn Technical Analysis Skills to Master the Stock Market
- Chewy Stock Surges on Roaring Kitty’s Disclosure of Major Stake
- Using the MarketBeat Dividend Yield Calculator
- How to Invest in Gold: A Complete Guide
- The How and Why of Investing in Gold Stocks
- 3 Stocks Wall Street Could Be Watching on Fannie Mae’s Rally
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.